Company profile
Aukera Therapeutics company profile
Aukera Therapeutics is a biotech company that develops novel therapeutics for patients suffering from mTOR protein-related diseases such as cancer and neurogenerative diseases. Aukera Therapeutics is a spin-off from the Biozentrum of the University of Basel.
Business identity
- Website
- https://www.aukera-tx.com
- Operating status
- Active
- Company type
- For Profit
- Employee range
- 1-10 employees
- Founded
- 2021-01-01, Year
Headquarters
- Headquarters
- Breíl, Grisons, Switzerland
- Postal code
- 4056
- Country code
- CH
- Continent
- Europe